|
SOCIETY FOR INHERITED METABOLIC DISORDERS 43rd Annual Meeting, April 10 - 13, 2022 Rosen Shingle Creek Resort, Orlando, Florida |
Monday, April 11, 2022 5:30-7:00pm Room: Suwanee 13-14 Dinner provided |
Tuesday, April 12, 2022 12:45-1:45 pm Room: Panzacola G Lunch available |
Tuesday, April 12, 2022 12:45-2:15 pm Room: Suwannee 16-17 Lunch served |
Tuesday, April 12, 2022 12:45-1:45 pm Room: Suwanee 13-14 Lunch served |
Tuesday, April 12, 2022 12:45-2:15 pm Room: Suwannee 19- 21 Lunch served |
UCD Care Considerations for Adolescent and Young Adult Patients |
The Evolving Treatment and Management Landscape for Patients with Long-Chain Fatty Acid Oxidation Disorders |
Advancing the Diagnosis and Management of a Rare Neurometabolic Disorder: A Focus on AADC Deficiency |
Screening, Diagnosis, Therapeutics and Advocacy for Urea Cycle Disorders |
Exploring Next Generation ERTs for Pompe Disease: Strategies for Individualizing Treatment Decisions |
Horizon-Sponsored Special Event | Presented by EXCEL Sposored by Ultragenyx Accredited for CME |
Organized and funded by PTC Therapeutics |
Organized by Acer Therapeutics | Jointly provided by AKH and Catalyst Medical Education. Accredited for CME. Supported by an educational grant from Sanofi Genzyme. |